Xingbo Long
Impact in
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Ferroptosis and cancer prognosis 5
- Prostate Cancer Diagnosis and Treatment 5
- Prostate Cancer Treatment and Research 5
- Surgery 10
- Bladder and Urothelial Cancer Treatments 8
- Urinary and Genital Oncology Studies 3
- Co-authors
- Yuan Li (4 shared papers)Lin Qi (3 shared papers)Yi Cai (2 shared papers)Tongxiang Diao (7 shared papers)Zhi Chen (1 shared paper)Miao Mo (1 shared paper)Huichuan Jiang (2 shared papers)Wei Xiong (1 shared paper)
- Journals
- PLoS ONE (3 papers)Cell Death and Disease (2 papers)Molecular Pharmaceutics (2 papers)Clinical and Translational Medicine (2 papers)The Journal of Pathology (1 paper)
- Partner nations
- ChinaUnited StatesMalawi
In The Last Decade
Xingbo Long
28 papers receiving 326 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 48
- Oncology 80
- Pulmonary and Respiratory Medicine 89
- Health 17
- Urology 12
Countries citing papers authored by Xingbo Long
This map shows the geographic impact of Xingbo Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Long more than expected).
Fields of papers citing papers by Xingbo Long
This network shows the impact of papers produced by Xingbo Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Long. The network helps show where Xingbo Long may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingbo Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 107 | |
| 2 | 2020 | 43 | |
| 3 | 2017 | 22 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 14 | |
| 6 | 2016 | 13 | |
| 7 | 2020 | 12 | |
| 8 | 2022 | 10 | |
| 9 | 2023 | 10 | |
| 10 | Identification and validation of an immune-related gene-based prognostic index for bladder cancer. | 2020 | 10 |
| 11 | 2020 | 10 | |
| 12 | 2025 | 9 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 6 | |
| 16 | Prognostic autophagy model based on CASP4 and BIRC5 expression in patients with renal cancer: independent datasets-based study. | 2020 | 5 |
| 17 | 2016 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2020 | 3 |
About Xingbo Long
Xingbo Long is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 31 papers that have together received 327 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Ferroptosis and cancer prognosis (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), Urinary and Genital Oncology Studies (3 papers) and Urologic and reproductive health conditions (2 papers). The work is most often cited by research in Cancer Research (48 citations), Oncology (80 citations), Pulmonary and Respiratory Medicine (89 citations), Health (17 citations) and Urology (12 citations). Xingbo Long has collaborated with scholars based in China, United States and Malawi. Frequent co-authors include Yuan Li, Lin Qi, Yi Cai, Tongxiang Diao, Zhi Chen, Miao Mo, Huichuan Jiang, Wei Xiong, Maolin Hu and Ming Liu. Their work appears in journals such as PLoS ONE, Cell Death and Disease, Molecular Pharmaceutics, Clinical and Translational Medicine and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.